1. Home
  2. SND vs TNYA Comparison

SND vs TNYA Comparison

Compare SND & TNYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Smart Sand Inc.

SND

Smart Sand Inc.

HOLD

Current Price

$5.45

Market Cap

204.2M

Sector

Industrials

ML Signal

HOLD

Logo Tenaya Therapeutics Inc.

TNYA

Tenaya Therapeutics Inc.

HOLD

Current Price

$0.73

Market Cap

171.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SND
TNYA
Founded
2011
2016
Country
United States
United States
Employees
318
N/A
Industry
Mining & Quarrying of Nonmetallic Minerals (No Fuels)
Medicinal Chemicals and Botanical Products
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
204.2M
171.4M
IPO Year
2016
2021

Fundamental Metrics

Financial Performance
Metric
SND
TNYA
Price
$5.45
$0.73
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$5.33
AVG Volume (30 Days)
298.1K
4.8M
Earning Date
05-05-2026
05-07-2026
Dividend Yield
2.81%
N/A
EPS Growth
N/A
54.96
EPS
N/A
N/A
Revenue
$330,153,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
6.03
N/A
52 Week Low
$1.76
$0.53
52 Week High
$5.84
$2.35

Technical Indicators

Market Signals
Indicator
SND
TNYA
Relative Strength Index (RSI) 58.04 40.54
Support Level $3.56 $0.65
Resistance Level $5.69 $0.82
Average True Range (ATR) 0.32 0.07
MACD 0.08 -0.01
Stochastic Oscillator 74.18 3.07

Price Performance

Historical Comparison
SND
TNYA

About SND Smart Sand Inc.

Smart Sand Inc. is a fully integrated frac sand company providing mine-to-well site proppant supply and logistics. It produces Northern White frac sand for enhanced hydrocarbon recovery in oil and gas wells. The company offers products like Smart System, SmartBelt, SmartDepot Silo, and SmartPath Loader. It is expanding into industrial markets, including glass, ceramics, and renewable energy, while its main revenue comes from sand sales and logistics. The company has two reportable segments, Sand and SmartSystems. It derives maximum revenue from Sand segment, which includes both frac sand sales and IPS sales. Geographically, the company derives maximum revenue from United States, followed by Canada.

About TNYA Tenaya Therapeutics Inc.

Tenaya Therapeutics Inc is a clinical-stage biotechnology company focused on the discovery and development of therapies targeting the underlying mechanisms of heart disease. It is developing therapies for rare genetic disorders as well as for more prevalent heart conditions through three distinct but interrelated product platforms: Gene Therapy, Cellular Regeneration and Precision Medicine. The company's clinical-stage gene therapy candidates include TN-201 and TN-401. It operates in one operating segment, which is the business of discovering and developing potential treatments that address the underlying drivers of heart disease.

Share on Social Networks: